Belite Bio BLTE
NASDAQ BLTE
$162.98 -6.84 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Long-Term Investments (2022 - 2025)

Updated

Belite Bio's Long-Term Investments was $280.17 million in Q4 2025, compared with $521,000 a year earlier.

Analysis

Belite Bio (BLTE) Long-Term Investments (2022 - 2025) Analysis & Trends

From Q4 2022 onward, Belite Bio has reported Long-Term Investments for 5 quarters.

  • Long-Term Investments shows a three-year compound annual growth rate of 603.1% (FY2022 to FY2025).
  • In earlier years, Long-Term Investments was $521,000 in FY2024 (-35.8%), $811,000 in FY2023 (+0.6%) and $806,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Belite Bio 6.68 Bn 6.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 280.17 Mn
Sep 30, 2025 509,000.00
Dec 31, 2024 521,000.00
Dec 31, 2023 811,000.00
Dec 31, 2022 806,000.00
API Access

Belite Bio Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BLTE&period=max&api_key=YOUR_API_KEY